This week The Medicine Men Column is short and not so sweet that is,
unless you like sugar-coated placebos. It's about one of the great ironies
of America's governmental mad medical system. Not just 'the more you pay,
the less you get' but 'the more medicine there is, the less you get.'
According to a 'News of the Day' release by The Association of American
Physicians and Surgeons, Inc. (AAPS) on November 1, 2005, "Medicare drug
plans may leave patients without their medications."
The problem is, as always, what the government will pay for. But this goes
beyond the usual refusal to provide care. The release notes further that
even if a drug is on a plan's formulary, a Medicare beneficiary may not be
able to get it under the new Medicare Part D benefit. Patients may not
discover this until they take their prescription to the pharmacy, at which
time they will be locked into the plan for a year.
The formulary (medicines on a plan's pharmacy list) is only one of the
cost-containment and -saving tools that a plan may use to restrict access.
Others include prior authorization by the insurance plan (after physician
and patient pleading); step therapy (or "fail first" with less expensive
and less effective medications); and quantity limits that create more red
tape for patients and doctors and may result in denials or critical delays
in receiving medications.
The tools posted at www.medicare.gov are incomplete and may be misleading,
according to the American Society of Consultant Pharmacists. ASCP has
developed a document that explains the restrictions to medication access,
posted at www.ascp.com/MedicareRx/docs/ASCPPartDMedAccess.pdf.
Story Continues Below
Coverage of some drugs is excluded by Congress (e.g., barbiturates,
benzodiazepines, nonprescription drugs). There are restrictions on all
drugs in certain classes, including statin drugs, proton pump inhibitors,
angiotensin II receptor antagonists, Alzheimer's disease drugs,
osteoporosis drugs, agents for benign prostatic hypertrophy, and many
others. More simply put: the ones you're most likely to use in your silver
and golden years.
Writes Thomas R. Clark, Director of Policy and Advocacy for ASCP,
"Physicians will also experience a tremendous administrative burden with
the advent of Medicare Part D. They will be expected to contact Part D
plans routinely for prescribing commonly used medications for Medicare
beneficiaries. This heavy administrative burden could result in many
physicians leaving the Medicare program, further exacerbataing the general
lack of access to physicians experienced by many Medicare beneficiaries."
As Jane Orient, M.D., Executive Director of AAPS, known for her well-informed clear vision and straightforward thinking, told me this morning,
"It's going to be a disaster."
So before you jump into another government plan, we suggest you carefully
check your required medicines against the Medicare Part D benefit list and
make a well-informed decision.
EDITOR'S NOTE: Michael Arnold Glueck submitted this week's commentary.
Robert J. Cihak, M.D., is a Senior Fellow and Board Member of the Discovery Institute and a past president of the Association of American Physicians and Surgeons. Michael Arnold Glueck, M.D., is a multiple-award-winning writer who comments on medical-legal issues.